The utilization of 3D printing- digital light processing (DLP) technique, for the direct fabrication of microneedles encounters the problem of drug solubility in printing resin, especially if it is predominantly composed of water. The possible solution how to ensure ideal belonging of drug and water-based printing resin is its pre-formulation in nanosuspension such as nanocrystals. This study investigates the feasibility of this approach on a resin containing nanocrystals of imiquimod (IMQ), an active used in (pre)cancerous skin conditions, well known for its problematic solubility and bioavailability. The resin blend of polyethylene glycol diacrylate and N-vinylpyrrolidone, and lithium phenyl-2,4,6-trimethylbenzoylphosphinate as a photoinitiator, was used, mixed with IMQ nanocrystals in water. The final microneedle-patches had 36 cylindrical microneedles arranged in a square grid, measuring approximately 600 μm in height and 500 μm in diameter. They contained 5wt% IMQ, which is equivalent to a commercially available cream. The homogeneity of IMQ distribution in the matrix was higher for nanocrystals compared to usual crystalline form. The release of IMQ from the patches was determined ex vivo in natural skin and revealed a 48% increase in efficacy for nanocrystal formulations compared to the crystalline form of IMQ.

Department of Organic Technology University of Chemistry and Technology Prague Faculty of Chemical Technology Technická 5 166 28 Prague 6 Czech Republic

Faculty of Chemical Technology Department of Organic Technology University of Chemistry and Technology Prague Technická 5 166 28 Prague Czech Republic

School of Pharmacy Queen's University Belfast 97 Lisburn Road BT9 7BL Belfast UK

Zobrazit více v PubMed

Peng K, Vora LK, Domínguez-Robles J, Naser YA, Li M, Larrañeta E, et al. Hydrogel-forming microneedles for rapid and efficient skin deposition of controlled release tip-implants. Mater Sci Eng C. 2021;127:112226. 10.1016/j.msec.2021.112226. PubMed DOI

Zhao Z, Chen Y, Shi Y, Microneedles. A potential strategy in transdermal delivery and application in the management of psoriasis. RSC Adv. 2020;10:14040–9. 10.1039/D0RA00735H. PubMed DOI PMC

Mathew E, Pitzanti G, Gomes dos Santos AL, Lamprou DA. Optimization of printing parameters for digital light processing 3d printing of hollow microneedle arrays. Pharmaceutics. 2021;13:1837. 10.3390/pharmaceutics13111837. PubMed DOI PMC

Dabbagh SR, Sarabi MR, Rahbarghazi R, Sokullu E, Yetisen AK, Tasoglu S. 3D-printed microneedles in biomedical applications. iScience. 2021;24:102012. 10.1016/j.isci.2020.102012. PubMed DOI PMC

Economidou SN, Lamprou DA, Douroumis D. 3D printing applications for transdermal drug delivery. Int J Pharm. 2018;544. 10.1016/j.ijpharm.2018.01.031.:415– 24. PubMed

Ahn D, Stevens LM, Zhou K, Page ZA. Rapid High-Resolution visible light 3D Printing. ACS Cent Sci. 2020;6:1555–63. 10.1021/acscentsci.0c00929. PubMed DOI PMC

Wang J, Goyanes A, Gaisford S, Basit AW. Stereolithographic (SLA) 3D printing of oral modified-release dosage forms. Int J Pharm. 2016;503:207–12. 10.1016/j.ijpharm.2016.03.016. PubMed DOI

Johnson AR, Caudill CL, Tumbleston JR, Bloomquist CJ, Moga KA, Ermoshkin A, et al. Single-step fabrication of computationally designed microneedles by continuous liquid interface production. PLoS ONE. 2016;11:e0162518. 10.1371/journal.pone.0162518. PubMed DOI PMC

Keirouz A, Mustafa YL, Turner JG, Lay E, Jungwirth U, Marken F, et al. Conductive polymer-coated 3D printed microneedles: Biocompatible platforms for minimally invasive Biosensing interfaces. Small. 2023;19:2206301. 10.1002/smll.202206301. PubMed DOI

Lim SH, Kathuria H, Amir MHB, Zhang X, Duong HT, Ho PC-L, et al. High resolution photopolymer for 3D printing of personalised microneedle for transdermal delivery of anti-wrinkle small peptide. J Control Release. 2021;329:907–18. 10.1016/j.jconrel.2020.10.021. PubMed DOI

Ghezzi M, Pescina S, Delledonne A, Ferraboschi I, Sissa C, Terenziani F, et al. Improvement of Imiquimod Solubilization and skin Retention via TPGS micelles: exploiting the Co-solubilizing Effect of Oleic Acid. Pharmaceutics. 2021;13:1476. 10.3390/pharmaceutics13091476. PubMed DOI PMC

Gazzi RP, Frank LA, Onzi G, Pohlmann AR, Guterres SS. New pectin-based hydrogel containing imiquimod-loaded polymeric nanocapsules for melanoma treatment. Drug Deliv Transl Res. 2020;10:1829–40. 10.1007/s13346-020-00805-5. PubMed DOI

Dias MF, Figueiredo BCPd, Teixeira-Neto J, Guerra MCA, Fialho SL, Silva Cunha A. In vivo evaluation of antitumoral and antiangiogenic effect of imiquimod-loaded polymeric nanoparticles. Biomed Pharmacother. 2018;103:1107–14. 10.1016/j.biopha.2018.04.079. PubMed DOI

Argenziano M, Haimhoffer A, Bastiancich C, Jicsinszky L, Caldera F, Trotta F, et al. In Vitro enhanced skin permeation and Retention of Imiquimod loaded in β-Cyclodextrin Nanosponge Hydrogel. Pharmaceutics. 2019;11:138. 10.3390/pharmaceutics11030138. PubMed DOI PMC

Stein P, Gogoll K, Tenzer S, Schild H, Stevanovic S, Langguth P, et al. Efficacy of Imiquimod-based Transcutaneous Immunization using a Nano-dispersed Emulsion Gel Formulation. PLoS ONE. 2014;9:e102664. 10.1371/journal.pone.0102664. PubMed DOI PMC

Petrová E, Chvíla S, Balouch M, Štěpánek F, Zbytovská J. Nanoformulations for dermal delivery of Imiquimod: the race of soft against hard. Int J Pharm. 2023;648:123577. 10.1016/j.ijpharm.2023.123577. PubMed DOI

Kalvodová A, Dvořáková K, Petrová E, Michniak-Kohn BB, Zbytovská J. The Contest of nanoparticles: searching for the most effective topical delivery of corticosteroids. Pharmaceutics. 2023;15:513. 10.3390/pharmaceutics15020513. PubMed DOI PMC

Larrañeta E, Moore J, Vicente-Pérez EM, González-Vázquez P, Lutton R, Woolfson AD, et al. A proposed model membrane and test method for microneedle insertion studies. Int J Pharm. 2014;472:65–73. 10.1016/j.ijpharm.2014.05.042. PubMed DOI PMC

Lambers H, Piessens S, Bloem A, Pronk H, Finkel P. Natural skin surface pH is on average below 5, which is beneficial for its resident flora. Int J Cosmet Sci. 2006;28:359–70. 10.1111/j.1467-2494.2006.00344.x. PubMed DOI

Braun-Falco O, Korting HC. [Normal pH value of human skin]. Hautarzt. 1986;37:126–9. 10.1016/j.isci.2020.102012. PubMed DOI

Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 2010;67:217–23. PubMed

Papadopoulou V, Kosmidis K, Vlachou M, Macheras P. On the use of the Weibull function for the discernment of drug release mechanisms. Int J Pharm. 2006;309:44–50. 10.1016/j.ijpharm.2005.10.044. PubMed DOI

Balireddi V, Tirukkovalluri SR, Murthy Tatikonda K, Surikutchi BT, Mitra P. Development and validation of stability indicating UPLC–PDA/MS for the determination of imiquimod and its eight related substances: application to topical cream. J Chromatogr Sci. 2019;57:249–57. 10.1093/chromsci/bmy108. PubMed DOI

White TJ, Liechty WB, Guymon CA. The influence of N-vinyl pyrrolidone on polymerization kinetics and thermo-mechanical properties of crosslinked acrylate polymers. J. Polym. Sci., Part A: Polym. Chem. 2007;45:4062-73. 10.1002/pola.22173.

He L, Lin D, Wang Y, Xiao Y, Che J. Electroactive SWNT/PEGDA hybrid hydrogel coating for bio-electrode interface. Colloids Surf B Biointerfaces. 2011;87:273–9. 10.1016/j.colsurfb.2011.05.028. PubMed DOI

Marimuthu E, Rathinam B, Murugesan V. Facile and green route polymerization of N-vinyl pyrrolidone under ultrasound-aided dual-site phase transfer catalytic conditions. Colloid Polym Sci. 2022;300:641–54. 10.1007/s00396-022-04979-x. DOI

Fares MM, Assaf SM, Abul-Haija YM. Pectin grafted poly (N‐vinylpyrrolidone): optimization and in vitro controllable theophylline drug release. J Appl Polym Sci. 2010;117:1945–54. 10.1002/app.32172. DOI

Donnelly RF, Majithiya R, Singh TRR, Morrow DIJ, Garland MJ, Demir YK, et al. Design, optimization and characterisation of polymeric microneedle arrays prepared by a Novel laser-based micromoulding technique. Pharm Res. 2011;28:41–57. 10.1007/s11095-010-0169-8. PubMed DOI PMC

Lee CY, Teymour F, Camastral H, Tirelli N, Hubbell JA, Elbert DL, et al. Characterization of the network structure of PEG diacrylate hydrogels formed in the presence of N-vinyl pyrrolidone. Macromol Reac Eng. 2014;8:314–28. 10.1002/mren.201300166. DOI

Jiménez-Sánchez G, Pavot V, Chane-Haong C, Handké N, Terrat C, Gigmes D, et al. Preparation and in vitro evaluation of imiquimod loaded polylactide-based micelles as potential vaccine adjuvants. Pharm Res. 2015;32:311–20. 10.1007/s11095-014-1465-5. PubMed DOI

El-Arini SK, Leuenberger H. Dissolution properties of praziquantel–PVP systems. Pharm Acta Helv. 1998;73:89–94. 10.1016/S0031-6865(97)00051-4. PubMed DOI

Katzhendler I, Hoffman A, Goldberger A, Friedman M. Modeling of Drug Release from Erodible tablets. J Pharm Sci. 1997;86:110–5. 10.1021/js9600538. PubMed DOI

Trucillo P, Drug Carriers. A review on the most used Mathematical models for Drug Release. Processes. 2022;10:1094. 10.3390/pr10061094. DOI

Sabri AH, Cater Z, Gurnani P, Ogilvie J, Segal J, Scurr DJ, et al. Intradermal delivery of imiquimod using polymeric microneedles for basal cell carcinoma. Int J Pharm. 2020;589:119808. 10.1016/j.ijpharm.2020.119808. PubMed DOI

HPMA polymers as functional excipients in dermal nanoformulations of imiquimod